Hansa Biopharma AB (publ) (LON:0RC7)

Hansa Biopharma AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	131	192	107	206	323	953
Market Cap Growth	1.54%	78.87%	-47.81%	-36.28%	-66.17%	251.50%
Enterprise Value	191	221	109	172	242	822
Last Close Price	1.93	2.82	2.09	3.91	7.24	21.48
PS Ratio	9.37	15.52	10.25	16.70	116.57	1753.27
PB Ratio	-2.73	-4.51	-8.18	4.28	5.21	8.61
P/TBV Ratio	-	-	-	4.47	5.42	8.83
EV/Sales Ratio	13.57	17.89	10.41	13.96	87.45	1512.21
Debt / Equity Ratio	-1.63	-1.83	-5.16	1.31	0.05	0.00
Asset Turnover	0.24	0.19	0.10	0.11	0.03	0.01
Inventory Turnover	42.01	40.53	50.80	63.34	90.74	-
Quick Ratio	1.82	2.22	2.57	5.91	5.33	12.13
Current Ratio	1.83	2.29	2.66	6.06	5.50	12.20
Return on Equity (ROE)	-	-	-382.37%	-89.84%	-54.84%	-46.63%
Return on Assets (ROA)	-46.04%	-43.41%	-36.55%	-26.67%	-27.56%	-25.32%
Return on Capital (ROIC)	-73.10%	-66.46%	-47.25%	-32.93%	-33.06%	-29.20%
Earnings Yield	-36.78%	-30.37%	-60.53%	-23.68%	-13.88%	-3.94%
FCF Yield	-37.51%	-25.39%	-55.02%	-19.61%	-12.25%	-2.72%
Buyback Yield / Dilution	-26.66%	-19.59%	-16.95%	-1.01%	-5.45%	-5.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.